Navigation Links
Repligen Elects Earl Henry, M.D. to the Board of Directors
Date:12/13/2007

e are the world's leading supplier of recombinant Protein A, the sales of which partially fund the advancement of our development pipeline while supporting our financial stability. Repligen's corporate headquarters are located at 41 Seyon Street, Building #1, Suite 100, Waltham, MA 02453. Additional information may be requested from http://www.repligen.com.

This press release contains forward-looking statements which are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements in this release do not constitute guarantees of future performance. Investors are cautioned that statements in this press release which are not strictly historical statements, including, without limitation, statements regarding current or future financial performance and position, management's strategy, plans and objectives for future operations, plans and objectives for product development, plans and objectives for present and future clinical trials and results of such trials, plans and objectives for regulatory approval, litigation, intellectual property, product development, manufacturing plans and performance such as the anticipated growth in the monoclonal antibody market and our other target markets and projected growth in product sales, constitute forward-looking statements. Such forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated, including, without limitation, risks associated with: the success of current and future collaborative relationships, the market acceptance of our products, our ability to compete with larger, better financed pharmaceutical and biotechnology companies, new approaches to the treatment of our targeted diseases, our expectation of incurring continued losses, our u
'/>"/>

SOURCE Repligen Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Repligen Reports Second Quarter Fiscal Year 2008 Financial Results
2. Repligen to Present at Upcoming Healthcare Conferences Wednesday, November 28th and Wednesday, December 5th
3. Mindray Selects Actel Low-Power Flash FPGAs for Demanding Medical Equipment Applications
4. Purdue Pharma Selects Systech to Provide Sustainable Infrastructure for Serialization
5. Loma Linda University Medical Center Selects Beryl to Manage Call Center Interactions for Womens Services Programs and Departments
6. West Penn Allegheny Health System Selects Electronic Health Record From Allscripts
7. ABMS Selects Kevin B. Weiss, MD, MPH, as New President and CEO
8. NIH selects Weill Cornell Medical College to lead new NYC translational research collaboration
9. Moffitt Selects Microsofts Azyxxi to Help Drive Personalized Cancer Treatment
10. Sandia National Laboratories Selects Allscripts Electronic Health Record and Practice Management for Employee Health Center
11. Delhaize Group Selects Trintechs AssureNET GL to Improve Compliance Process Efficiency
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... ... July 30, 2015 , ... Ross A. Clevens, ... of Medicine as Assistant Professor of Plastic Surgery. This is Dr. Clevens’ second ... worked closely with the university, developing a strong presence and a valuable mentoring program ...
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... Using the ... suicide and teach people more effective ways to prevent and manage major depression. , ... react fast enough, so people fall through the cracks and die needlessly everyday,” says ...
(Date:7/30/2015)... ... July 30, 2015 , ... Between 2012 and 2014 ... Health News Florida on June 17th. Those untreated heroin use disorders share ... prevent the spread of dirty needles throughout the community. Ultimately Florida’s HIV infection rates ...
(Date:7/30/2015)... ... July 30, 2015 , ... The American Association of ... announcement of the reinstitution of National Prescription Drug Take-Back Days. The 10th event ... AM to 2:00 PM local time. On the 26th, the DEA, with the ...
(Date:7/30/2015)... ... July 30, 2015 , ... InventHelp, a leading ... designed a personal-care device that makes it easy to apply lotion or medication to ... need for assistance when applying lotion or medication to the back, and provides thorough ...
Breaking Medicine News(10 mins):Health News:Leading Melbourne Facial Plastic Surgeon Reappointed by UCF 2Health News:Leading Melbourne Facial Plastic Surgeon Reappointed by UCF 3Health News:Happiness Expert Develops Pioneering Online Tools for Sufferers of Major Depression, and Who may be Suicidal 2Health News:Happiness Expert Develops Pioneering Online Tools for Sufferers of Major Depression, and Who may be Suicidal 3Health News:HIV Rates Rise in S. Florida, Harbor Village Comments on Health News Florida's Recent Article 2Health News:HIV Rates Rise in S. Florida, Harbor Village Comments on Health News Florida's Recent Article 3Health News:AAPCC Supports National Prescription Drug Take-Back Day 2Health News:AAPCC Supports National Prescription Drug Take-Back Day 3Health News:InventHelp® Client Patents “My Back Buddy” – Device Could Apply Lotion to Hard-to-Reach Areas Easily 2
... NEW HOPE, Pa. and LOUISVILLE, Ky., Aug. 10 As part ... Products to bring its unique, family-friendly weight-loss product to stores across ... often a family problem, and Slimbolics provides a solution that the ... product to quell her and her daughter,s desires for junk food. ...
... NBTY, Inc. (NYSE: NTY ) ( www.NBTY.com ), ... it will web cast the presentation by Harvey Kamil, President and Chief ... Conference in Boston on Thursday, August 13, 2009. , , ... Company Web site, www.nbty.com , on Thursday, August 13 ...
... PITTSBURGH, Aug. 10 The Allegheny County ... misinforming the public regarding vaccine requirements for the upcoming ... , , The Health Department, in ... parents that up-to-date immunizations are required for school attendance ...
... , UNION CITY, Calif., Aug. 10 ... company manufacturing point-of-care blood analysis instruments for both the medical ... to the position of vice president of North American medical ... the Abaxis Board of Directors since 1996, has resigned his ...
... , , EAST BRUNSWICK, N.J., ... today reported financial results for the three and six months ended ... and short-term investments, a reduction of $2.0 million from December 31, ... from our registered direct offering in April 2009, our cash burn ...
... /PRNewswire-Asia/ -- Chindex International, Inc.,("Chindex") (Nasdaq: CHDX ), ... in the People,s Republic of China, today,announced results for its ... First Quarter Fiscal 2010 Financial Results ... of fiscal 2010, which ended June 30, 2009,increased 41% to ...
Cached Medicine News:Health News:Slimbolics Signs Marketing Contract for Its Revolutionary Weight Loss Aid 2Health News:NBTY to Web Cast Presentation at Canaccord Adams Global Growth Conference; Announces Preliminary Unaudited Net Sales Results for July 2009 2Health News:NBTY to Web Cast Presentation at Canaccord Adams Global Growth Conference; Announces Preliminary Unaudited Net Sales Results for July 2009 3Health News:Allegheny County Health Department and School Districts Misinforming the Public 2Health News:ABAXIS Announces Appointment of Brenton Hanlon to Vice President of North American Medical Sales and Marketing 2Health News:ABAXIS Announces Appointment of Brenton Hanlon to Vice President of North American Medical Sales and Marketing 3Health News:Savient Pharmaceuticals Reports Second Quarter 2009 Financial Results 2Health News:Savient Pharmaceuticals Reports Second Quarter 2009 Financial Results 3Health News:Savient Pharmaceuticals Reports Second Quarter 2009 Financial Results 4Health News:Savient Pharmaceuticals Reports Second Quarter 2009 Financial Results 5Health News:Savient Pharmaceuticals Reports Second Quarter 2009 Financial Results 6Health News:Savient Pharmaceuticals Reports Second Quarter 2009 Financial Results 7Health News:Savient Pharmaceuticals Reports Second Quarter 2009 Financial Results 8Health News:Savient Pharmaceuticals Reports Second Quarter 2009 Financial Results 9Health News:Savient Pharmaceuticals Reports Second Quarter 2009 Financial Results 10Health News:Savient Pharmaceuticals Reports Second Quarter 2009 Financial Results 11Health News:Savient Pharmaceuticals Reports Second Quarter 2009 Financial Results 12Health News:Savient Pharmaceuticals Reports Second Quarter 2009 Financial Results 13Health News:Savient Pharmaceuticals Reports Second Quarter 2009 Financial Results 14Health News:Chindex International, Inc. Reports First Quarter Fiscal 2010 Financial Results 2Health News:Chindex International, Inc. Reports First Quarter Fiscal 2010 Financial Results 3Health News:Chindex International, Inc. Reports First Quarter Fiscal 2010 Financial Results 4Health News:Chindex International, Inc. Reports First Quarter Fiscal 2010 Financial Results 5Health News:Chindex International, Inc. Reports First Quarter Fiscal 2010 Financial Results 6Health News:Chindex International, Inc. Reports First Quarter Fiscal 2010 Financial Results 7Health News:Chindex International, Inc. Reports First Quarter Fiscal 2010 Financial Results 8Health News:Chindex International, Inc. Reports First Quarter Fiscal 2010 Financial Results 9Health News:Chindex International, Inc. Reports First Quarter Fiscal 2010 Financial Results 10
(Date:7/30/2015)... , July 30, 2015  Arena Pharmaceuticals, Inc. ... a conference call and webcast at 5:00 p.m. Eastern ... 2015, to discuss second quarter 2015 financial results and ... results after the NASDAQ Global Select Market closes that ... by dialing 877.643.7155 for domestic callers and 914.495.8552 for ...
(Date:7/30/2015)... HeartWare International, Inc . (NASDAQ: HTWR ), ... support technologies that are revolutionizing the treatment of ... $73.6 million for the quarter ended June 30, ... ended June 30, 2014.  Currency fluctuations impacted revenue ... points, during the three months ended June 30, ...
(Date:7/29/2015)... OSAKA, Japan , ... -- ... confirmed,   including Core ... EPS    ... Underlying revenue +6.1% year-to-year (reported revenue growing +8.5% to 446.3 billion yen) ...
Breaking Medicine Technology:Arena Pharmaceuticals to Host Second Quarter 2015 Financial Results and Corporate Update Conference Call and Webcast on Wednesday, August 5 2Arena Pharmaceuticals to Host Second Quarter 2015 Financial Results and Corporate Update Conference Call and Webcast on Wednesday, August 5 3Arena Pharmaceuticals to Host Second Quarter 2015 Financial Results and Corporate Update Conference Call and Webcast on Wednesday, August 5 4HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 2HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 3HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 4HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 5HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 6HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 7HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 8HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 9HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 10HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 11HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 12HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 13HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 14Takeda Reports 1st Quarter Results of FY2015 with Underlying Revenue Growth of +6.1% 2Takeda Reports 1st Quarter Results of FY2015 with Underlying Revenue Growth of +6.1% 3Takeda Reports 1st Quarter Results of FY2015 with Underlying Revenue Growth of +6.1% 4Takeda Reports 1st Quarter Results of FY2015 with Underlying Revenue Growth of +6.1% 5
... PRINCETON, N.J., Feb. 7, 2011 Pharmasset, Inc. (Nasdaq: ... committed to discovering, developing, and commercializing novel drugs to ... highlights for the quarter ended December 31, 2010. ... the quarter ended December 31, 2010 compared to $0.3 ...
... Sangamo BioSciences, Inc. (Nasdaq: SGMO ) announced today ... update on the progress of Sangamo,s ZFP Therapeutic® development programs ... pm ET on Monday, February 14, 2011 at the 13th ... in New York City. The presentation will be ...
Cached Medicine Technology:Pharmasset Reports Fiscal First Quarter 2011 Financial Results 2Pharmasset Reports Fiscal First Quarter 2011 Financial Results 3Pharmasset Reports Fiscal First Quarter 2011 Financial Results 4Pharmasset Reports Fiscal First Quarter 2011 Financial Results 5Pharmasset Reports Fiscal First Quarter 2011 Financial Results 6Sangamo BioSciences Announces Presentation at the 13th Annual BIO CEO & Investor Conference 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: